Jose Marenco1, Clement Orczyk2,3, Tom Collins2, Caroline Moore2,3, Mark Emberton2,3. 1. University College London Hospital, NHS Foundation Trust, 47 Wimpole Street, Marylebone, London, W1G 8SE, UK. jlmarencoj@gmail.com. 2. University College London Hospital, NHS Foundation Trust, 47 Wimpole Street, Marylebone, London, W1G 8SE, UK. 3. Division of Surgery and Interventional Science, University College of London, London, UK.
Abstract
INTRODUCTION: The goal of radical prostatectomy is to eradicate oncological disease while achieving the best possible functional outcomes. In this regard, nerve sparing offers a greater chance of recovering potency after surgery. Accurately locating prostate cancer foci is instrumental for identifying good candidates for this approach whilst maintaining safe oncological margins. In addition to this, the length of membranous urethra is an independent predictor of time to, and extent of, continence recovery. The introduction of Mp-MRI allows visualising malignant tissue within the prostate gland, which could lead to image-directed surgery planning as with other solid-organ cancers such as kidney, pancreas, breast or testes. METHODS: A narrative review of the available literature was performed. RESULTS: Mp-MRI demonstrated moderate sensitivity and high specificity to detect extra-capsular extension, seminal vesicle involvement or T3 stage. Measurements of membranous urethral length have shown to be useful in predicting probability of achieving continence after surgery. Furthermore, image-guided surgery has shown to be accurate to determine surgical planes to safely preserve neurovascular bundles. CONCLUSION: The use of Mp-MRI for pre-surgical planning introduces a new scenario where the previously homogeneous radical prostatectomy can be tailored to suit patient and tumour features. This has the potential to improve functional outcomes whilst not compromising on surgical margins. Moreover, the introduction of Mp-MRI increases the ability to predict functional outcomes after surgery and allows for a more accurate local staging. This in turn provides more information to both patients and clinicians in the decision-making process regarding treatment.
INTRODUCTION: The goal of radical prostatectomy is to eradicate oncological disease while achieving the best possible functional outcomes. In this regard, nerve sparing offers a greater chance of recovering potency after surgery. Accurately locating prostate cancer foci is instrumental for identifying good candidates for this approach whilst maintaining safe oncological margins. In addition to this, the length of membranous urethra is an independent predictor of time to, and extent of, continence recovery. The introduction of Mp-MRI allows visualising malignant tissue within the prostate gland, which could lead to image-directed surgery planning as with other solid-organ cancers such as kidney, pancreas, breast or testes. METHODS: A narrative review of the available literature was performed. RESULTS: Mp-MRI demonstrated moderate sensitivity and high specificity to detect extra-capsular extension, seminal vesicle involvement or T3 stage. Measurements of membranous urethral length have shown to be useful in predicting probability of achieving continence after surgery. Furthermore, image-guided surgery has shown to be accurate to determine surgical planes to safely preserve neurovascular bundles. CONCLUSION: The use of Mp-MRI for pre-surgical planning introduces a new scenario where the previously homogeneous radical prostatectomy can be tailored to suit patient and tumour features. This has the potential to improve functional outcomes whilst not compromising on surgical margins. Moreover, the introduction of Mp-MRI increases the ability to predict functional outcomes after surgery and allows for a more accurate local staging. This in turn provides more information to both patients and clinicians in the decision-making process regarding treatment.
Authors: Fergus V Coakley; Steven Eberhardt; Michael W Kattan; David C Wei; Peter T Scardino; Hedvig Hricak Journal: J Urol Date: 2002-09 Impact factor: 7.450
Authors: Nazareno Suardi; Marco Moschini; Andrea Gallina; Giorgio Gandaglia; Firas Abdollah; Umberto Capitanio; Marco Bianchi; Manuela Tutolo; Niccolò Passoni; Andrea Salonia; Petter Hedlund; Patrizio Rigatti; Francesco Montorsi; Alberto Briganti Journal: BJU Int Date: 2012-06-21 Impact factor: 5.588
Authors: Philippe Paparel; Oguz Akin; Jaspreet S Sandhu; Javier Romero Otero; Angel M Serio; Peter T Scardino; Hedvig Hricak; Bertrand Guillonneau Journal: Eur Urol Date: 2008-09-02 Impact factor: 20.096
Authors: Vincenzo Ficarra; Giacomo Novara; Raymond C Rosen; Walter Artibani; Peter R Carroll; Anthony Costello; Mani Menon; Francesco Montorsi; Vipul R Patel; Jens-Uwe Stolzenburg; Henk Van der Poel; Timothy G Wilson; Filiberto Zattoni; Alexandre Mottrie Journal: Eur Urol Date: 2012-06-01 Impact factor: 20.096
Authors: A M Hövels; R A M Heesakkers; E M Adang; G J Jager; S Strum; Y L Hoogeveen; J L Severens; J O Barentsz Journal: Clin Radiol Date: 2008-02-04 Impact factor: 2.350
Authors: Armando Stabile; Francesco Giganti; Andrew B Rosenkrantz; Samir S Taneja; Geert Villeirs; Inderbir S Gill; Clare Allen; Mark Emberton; Caroline M Moore; Veeru Kasivisvanathan Journal: Nat Rev Urol Date: 2019-07-17 Impact factor: 14.432
Authors: Antonio Cordeiro da Silva Filho; Tamara Oliveira Rocha; Jorge Elias; Marcus Vinicius de Castro Barros; Alfredo Ribeiro Silva; Rodolfo Borges Dos Reis; Valdair Francisco Muglia Journal: Radiol Bras Date: 2020 Nov-Dec
Authors: Mike Wenzel; Felix Preisser; Matthias Mueller; Lena H Theissen; Maria N Welte; Benedikt Hoeh; Clara Humke; Simon Bernatz; Boris Bodelle; Christoph Würnschimmel; Derya Tilki; Hartwig Huland; Markus Graefen; Frederik C Roos; Andreas Becker; Pierre I Karakiewicz; Felix K H Chun; Luis A Kluth; Philipp Mandel Journal: Int Urol Nephrol Date: 2021-02-19 Impact factor: 2.370
Authors: Benedikt Hoeh; Mike Wenzel; Matthias Müller; Clarissa Wittler; Eva Schlenke; Jan L Hohenhorst; Jens Köllermann; Thomas Steuber; Markus Graefen; Derya Tilki; Simon Bernatz; Pierre I Karakiewicz; Felix Preisser; Andreas Becker; Luis A Kluth; Philipp Mandel; Felix K H Chun Journal: Diagnostics (Basel) Date: 2022-03-13